List of Excipients in API LORLATINIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing LORLATINIB
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Pfizer Laboratories Div Pfizer Inc | LORBRENA | lorlatinib | 0069-0227 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2038-10-04 |
Pfizer Laboratories Div Pfizer Inc | LORBRENA | lorlatinib | 0069-0227 | CELLULOSE, MICROCRYSTALLINE | 2038-10-04 |
Pfizer Laboratories Div Pfizer Inc | LORBRENA | lorlatinib | 0069-0227 | FERRIC OXIDE RED | 2038-10-04 |
Pfizer Laboratories Div Pfizer Inc | LORBRENA | lorlatinib | 0069-0227 | FERROSOFERRIC OXIDE | 2038-10-04 |
Pfizer Laboratories Div Pfizer Inc | LORBRENA | lorlatinib | 0069-0227 | HYPROMELLOSE | 2038-10-04 |
Pfizer Laboratories Div Pfizer Inc | LORBRENA | lorlatinib | 0069-0227 | LACTOSE MONOHYDRATE | 2038-10-04 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for LORLATINIB
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
LORLATINIB drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
LORLATINIB drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
LORLATINIB drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
LORLATINIB drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
LORLATINIB drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
LORLATINIB drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
LORLATINIB drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
LORLATINIB drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
LORLATINIB drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
LORLATINIB drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
LORLATINIB drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | lorlatinib | 0069-0227 |
US Pharmaceuticals | lorlatinib | 63539-927 |
>Company | >Ingredient | >NDC |
LORLATINIB drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.